SUPNSUPERNUS PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of SUPERNUS PHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPNThis | $1.7B#4 | — | 1.6x#3 | 2.4x#1 | 8.6%#7 | -152.2%#10 | -8.7%#4 | -3.6%#5 | -4.8%#4 | — | — | — |
| SLS | $1.8B#3 | — | 12.9x#8 | — | -100.0%#9 | 13.0%#5 | — | -19.5%#7 | — | — | — | — |
| STOK | $1.8B#2 | — | 5.1x#5 | 9.7x#4 | 404.5%#2 | 92.3%#3 | -11.2%#5 | -2.0%#4 | — | — | — | — |
| NUVB | $1.7B#5 | — | 6.6x#6 | 26.5x#6 | 699.0%#1 | 64.0%#4 | -338.7%#7 | -80.6%#9 | -87.4%#5 | — | — | — |
| RARE | $1.7B#6 | — | — | 2.5x#2 | 20.2%#5 | -1.1%#6 | -79.5%#6 | — | — | — | — | — |
| TRAX | $1.9B#1 | — | 12.8x#7 | — | — | -1.5%#7 | — | -110.0%#10 | — | — | — | — |
| KLRA | $1.6B#7 | — | 1.5x#2 | — | — | — | — | 0.0%#3 | — | — | — | — |
| ANIP | — | 15.6x#2 | — | — | 43.8%#4 | 510.5%#2 | 12.6%#2 | 13.1%#2 | 16.9%#1 | — | -23.7%#3 | — |
| INVA | $1.5B#8 | 4.9x#1 | 1.2x#1 | 3.7x#3 | 14.7%#6 | 1059.2%#1 | 39.8%#1 | 22.0%#1 | 14.7%#2 | 5#1 | 16.2%#2 | — |
| OCUL | $1.5B#9 | — | 2.9x#4 | 29.1x#7 | -18.5%#8 | -37.4%#9 | -519.8%#8 | -51.1%#8 | — | — | -39.6%#4 | — |
| ETON | $1.5B#10 | — | 31.4x#9 | 18.3x#5 | 104.9%#3 | -20.4%#8 | -1.1%#3 | -9.9%#6 | -1.8%#3 | 4#2 | 185.2%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice